As such, this cellular model allowed us to unmask AURK and AKT as additional CDK6-controlled vulnerabilities in AML cells: in fact, CDK6 binds onto the chromatin and facilitates transcription of the oncogenic kinases AURK and AKT in a kinase-dependent manner. Here, CDK6 is linked to acute myeloid leukemia.